# Drug Use Investigation for Arepanrix® (H1N1)

> **NCT02069496** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 3405 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Arepanrix®

## Key facts

- **NCT ID:** NCT02069496
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-02
- **Primary completion:** 2010-07
- **Final completion:** 2010-10
- **Target enrollment:** 3405 (ACTUAL)
- **Last updated:** 2014-02-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02069496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02069496, "Drug Use Investigation for Arepanrix® (H1N1)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02069496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*